Blockchain Registration Transaction Record

Oncotelic Advances Nanotech Drug Delivery to Transform Oncology

Oncotelic Therapeutics advances Sapu003 and Deciparticle platform using nanotechnology and AI to improve oncology drug delivery, aligning with industry trends toward platform-based models.

This news matters because it highlights a pivotal shift in oncology: instead of chasing new drugs, companies like Oncotelic are optimizing existing therapies with nanotechnology and AI, potentially speeding up access to more effective treatments. For patients, this could mean better outcomes with fewer side effects; for investors, it signals a lower-risk, higher-reward strategy in biotech. The integration of AI into drug delivery also represents a leap toward personalized medicine, making treatments more precise and scalable.